SCHEMBL837325

SCHEMBL837325

CCOC(=O)c1nccs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
PKM P14618 3/20 0.53
MAPT P10636 4/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 2/20 0.43
RBBP9 O75884 2/20 0.43
HPGD P15428 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK1 P28482 1/20 0.43
NPC1 O15118 3/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL29000634 0.98 ALDH1A1 (0.53) ALDH1A1PKMMAPTHTTLMNA
Hydrochloric Acid SCHEMBL14763613 0.98 ALDH1A1 (0.53) ALDH1A1PKMMAPTHTTLMNA
Piperazine SCHEMBL27525909 0.91 ALDH1A1 (0.46) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL25242978 0.83 ALDH1A1 (0.57) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL25243570 0.83 ALDH1A1 (0.52) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL27647394 0.83 L3MBTL1 (0.58) ALDH1A1PKMLMNAHSD17B10MAPK1
SCHEMBL3219037 0.82 ALDH1A1 (0.58) ALDH1A1PKMMAPTHTTLMNA
Ethyl Acetate SCHEMBL15874941 0.81 ALDH1A1 (0.70) ALDH1A1PKMMAPTHTTLMNA
SCHEMBL27444649 0.80 L3MBTL1 (0.52) ALDH1A1MAPTLMNARAB9AKDM4E
SCHEMBL1489443 0.80 ALDH1A1 (0.51) ALDH1A1PKMMAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-218339475-U Extraction device of thiazole carboxylic acid ethyl ester 安徽勇晟医药科技有限公司 2023-01-20 CN claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US claimed
CN-105924406-B A kind of preparation method of acotiamide hydrochloride trihydrate 河北国龙制药有限公司 2018-04-10 CN claimed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 US claimed
CN-102388027-B Isothiazolyloxyphenylamidines and their use as fungicides BAYER CROPSCIENCE AG 2015-07-01 CN claimed
CN-103788084-A Tetrahydroisoquinoline derivative and synthesis method thereof Hunan huateng pharmaceutical co ltd 2014-05-14 CN claimed
JP-9188670-A None JP disclosed
US-20250188094-A1 PYRAZOLE MEMBRANE-ASSOCIATED TYROSINE-AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF INSILICO MEDICINE LTD. (CN) 2025-06-12 US disclosed
EP-4493557-A1 PYRAZOLE MEMBRANE-ASSOCIATED TYROSINE-AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF Insilico Medicine IP Limited (HK) 2025-01-22 EP disclosed
CN-119192103-A Five-membered heterocyclic amide compound, preparation method and application thereof, and bactericide 贵州大学 2024-12-27 CN disclosed
CN-119053592-A Pyrazole membrane-associated tyrosine and threonine specific CDC2 inhibitor kinase (PKMYT 1) inhibitors and uses thereof 英矽智能科技知识产权有限公司 2024-11-29 CN disclosed
CN-118339274-A Brandy replica 艾娃食品实验室股份有限公司 2024-07-12 CN disclosed
CN-117374383-A Eutectic solid electrolyte for lithium metal battery and preparation method and application thereof 南开大学 2024-01-09 CN disclosed
EP-0571471-B1 5-HETEROYL INDOLE DERIVATIVES PFIZER (US) 1996-03-06 EP disclosed
US-5409941-A 5-heteroyl indole derivatives PFIZER INC. (US) 1995-04-25 US disclosed
CN-1081675-A By the new pyrethroid of thiazolic alcohol derivative, its preparation method and as the purposes of agricultural chemicals ROUSSEL UCLAF (FR) 1994-02-09 CN disclosed
EP-0571471-A1 5-HETEROYL INDOLE DERIVATIVES. PFIZER (US) 1993-12-01 EP disclosed
WO-1992013856-A1 5-HETEROYL INDOLE DERIVATIVES PFIZER INC. (US) 1992-08-20 WO disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed
CN-1048386-A Novel thiazole base alkoxy acrylic ester, they the preparation method, do the purposes of mycocide and prepare the intermediate of this compounds ROUSSEL UCLAF (FR) 1991-01-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10224485-B2 Process for preparing a crystalline organic semiconductor material STOM, SPOP, TTR ALDH1A1 4757/4885PKM 2108/4885MAPT 150/4885
US-20250188094-A1 PYRAZOLE MEMBRANE-ASSOCIATED TYROSINE-AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE (PKMYT1) INHIBITORS AND USES THEREOF PKMYT1, LMTK2, MAST1 ALDH1A1 4768/4885PKM 73/4885MAPT 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.